Custopharm Revenue and Competitors
Estimated Revenue & Valuation
- Custopharm's estimated annual revenue is currently $5.4M per year.
- Custopharm's estimated revenue per employee is $201,000
Employee Data
- Custopharm has 27 Employees.
- Custopharm grew their employee count by -40% last year.
Custopharm's People
Name | Title | Email/Phone |
---|---|---|
1 | Snr. Director Commercial Operations/Supply Chain/Project Management | Reveal Email/Phone |
2 | Director Technology Transfer and Manufacturing | Reveal Email/Phone |
3 | Sr. Manager, Quality Control | Reveal Email/Phone |
4 | Quality Assurance Manager | Reveal Email/Phone |
5 | Sr. Associate, Regulatory Affairs | Reveal Email/Phone |
6 | method development chemist | Reveal Email/Phone |
7 | Principal Scientist | Reveal Email/Phone |
8 | Scientist, Analytical Development | Reveal Email/Phone |
9 | Analytical Development Scientist | Reveal Email/Phone |
Custopharm Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Custopharm?
Founded in 2005, Custopharm has steadily grown to develop more than 30 products and serve more than 100 organizations across the pharmaceutical industry. In 2015 we partnered with Water Street Healthcare Partners, a strategic investor with extensive pharmaceutical expertise, to accelerate Custopharm's growth. Since then, we have been working towards becoming a U.S. leader in generic injectable drugs while striving to make therapies more accessible through our development portfolio of high barrier products. The Company is presently in an early commercial stage, with aggressive growth anticipated. Leucadia Pharmaceuticals was established in 2015 as the commercial arm of Custopharm, Inc., and is associated with Water Street Healthcare Partners.
keywords:N/AN/A
Total Funding
27
Number of Employees
$5.4M
Revenue (est)
-40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Custopharm News
Hikma Pharmaceuticals has acquired US-based generic sterile injectables company Custopharm from Water Street Healthcare Partners in a deal...
Working with the company's leadership team, Water Street transformed Custopharm into a leading franchise offering a portfolio of differentiated...
WASHINGTON, April 19 (Reuters) - Generic drug maker Hikma Pharmaceuticals (HIK.L) has won U.S. antitrust approval to buy Custopharm,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 27 | 13% | N/A |
#2 | N/A | 27 | -10% | N/A |
#3 | $2.7M | 27 | 0% | N/A |
#4 | $3.3M | 27 | 4% | N/A |
#5 | $2.7M | 27 | N/A | N/A |